Adhera Therapeutics to Collaborate with Alberta Diabetes
Data will be instrumental in upcoming Phase 2 clinical trial of MLR-1023, Adhera’s novel Type 1 Diabetes drug candidateCompany moving forward with...
Source: globenewswire.com
Stay updated with breaking news from Zahed Subhan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data will be instrumental in upcoming Phase 2 clinical trial of MLR-1023, Adhera’s novel Type 1 Diabetes drug candidateCompany moving forward with...
GuruFocus Article or News written by GuruFocusNews and the topic is about: